Insurance coverage of blockbuster obesity drugs has been spotty at best over the years, and it looks like things are getting worse, not better. Plans are dropping coverage or restricting it further.
Originally reported by NPR
Data assessed from 17 clinical trials of anti-amyloid drugs found no ‘meaningful effect’ on cognitive declineDrugs that ...
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analys...
A man wearing a ‘falls detector’. RoSPA said falls from standing among elderly people were some of the most common acci...
Health Middle East conflict causes a fluoride shortage for US drinking water April 15, 20264:38 PM ET Pien Huang...